Related Experiment Video
Updated: Feb 13, 2026

Quantitative Analysis of Autophagy using Advanced 3D Fluorescence Microscopy
Published on: May 3, 2013
FOXO3a Provides a Quickstep from Autophagy Inhibition to Apoptosis in Cancer Therapy
Patrice Codogno1, Etienne Morel1
1INSERM U1151-CNRS UMR 8253, Institut Necker Enfants-Malades (INEM), 70014 Paris, France; Université Paris Descartes-Sorbonne Paris Cité, 70006 Paris, France.
Abstract:
FOXO3a, a member of the Forkhead transcription factor family, has roles in apoptosis and autophagy. In this issue of Developmental Cell, Fitzwalter et al. (2018) describe how the blockade of FOXO3a turnover, which normally occurs through autophagy, sensitizes cancer cells to apoptosis through FOXO3a-mediated stimulation of pro-apoptotic PUMA/BBC3 expression.
Insights
Blocking the turnover of FOXO3a (Forkhead box O3) via autophagy enhances cancer cell apoptosis. This occurs through increased expression of the pro-apoptotic protein PUMA/BBC3, mediated by FOXO3a.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- FOXO3a, a transcription factor, regulates apoptosis and autophagy.
- Autophagy typically facilitates FOXO3a turnover.
- Dysregulation of these processes is implicated in cancer.
Purpose of the Study:
- To investigate the consequences of blocking FOXO3a turnover via autophagy.
- To elucidate the role of FOXO3a in cancer cell apoptosis.
Main Methods:
- Cellular assays to monitor FOXO3a levels and turnover.
- Analysis of PUMA/BBC3 expression.
- Assessment of apoptosis induction in cancer cells.
Main Results:
- Inhibition of autophagy led to the blockade of FOXO3a turnover.
- Blocked FOXO3a turnover sensitized cancer cells to apoptosis.
- FOXO3a-mediated upregulation of PUMA/BBC3 expression was observed.
Conclusions:
- FOXO3a turnover through autophagy is a critical regulatory mechanism.
- Blocking this turnover enhances cancer cell apoptosis by upregulating PUMA/BBC3.
- Targeting FOXO3a turnover represents a potential therapeutic strategy for cancer.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Apoptosis
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Feedback Inhibition
Enzyme Inhibition

